Literature DB >> 21839113

Impact of pandemic A/H1N1/2009 influenza on children and their families: comparison with seasonal A/H1N1 and A/H3N2 influenza viruses.

Susanna Esposito1, Claudio Giuseppe Molteni, Cristina Daleno, Claudia Tagliabue, Irene Picciolli, Alessia Scala, Claudio Pelucchi, Emilio Fossali, Nicola Principi.   

Abstract

OBJECTIVES: To make a direct comparison between the total burden of pandemic influenza and that of other seasonal influenza A viral subtypes in otherwise healthy children.
METHODS: The total clinical and socioeconomic burden of pandemic A/H1N1/2009 influenza was compared with that of seasonal influenza A viral subtypes in 389 otherwise healthy children with A/H1N1/2009, 126 with seasonal A/H1N1 and 486 with seasonal A/H3N2 infection referred to the Emergency Room and hospitalised in the in-patient units of a large, university-based paediatric hospital. Influenza diagnosis was confirmed by real-time polymerase chain reaction.
RESULTS: Regardless of age or gender, the variables significantly associated with pandemic A/H1N1/2009 and seasonal A/H3N2 infection were a diagnosis of lower respiratory tract infection upon clinical presentation, the need for hospitalisation, hospitalisation for ≥7 days, school absences of ≥7 days, the need for aerosol therapy, the household development of a disease similar to that of the infected child, and the need for additional household medical visits and antibiotic prescriptions (p < 0.001). A longer period of hospitalisation and lost school days seemed to be associated with pandemic A/H1N1/2009 infection (p < 0.01).
CONCLUSIONS: Perceived symptom severity and the risk of serious outcomes are similar in children with influenza due to pandemic A/H1N1/2009 or seasonal A/H3N2 influenza, but both of these viruses seem to have a greater clinical and socioeconomic impact than seasonal A/H1N1 virus, regardless of the patients' age or gender.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21839113     DOI: 10.1016/j.jinf.2011.07.015

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  9 in total

Review 1.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

2.  Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan.

Authors:  Yasuhiro Kamioka; Shota Kashiwagura; Masafumi Seki
Journal:  Clin Pharmacol       Date:  2020-08-21

3.  Similar severity of influenza primary and re-infections in pre-school children requiring outpatient treatment due to febrile acute respiratory illness: prospective, multicentre surveillance study (2013-2015).

Authors:  Andrea Streng; Christiane Prifert; Benedikt Weissbrich; Andreas Sauerbrei; Andi Krumbholz; Ruprecht Schmidt-Ott; Johannes G Liese
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

4.  Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.

Authors:  Young Jae Lee; Ji Eun Yu; Paul Kim; Jeong-Yoon Lee; Yu Cheol Cheong; Yoon Jae Lee; Jun Chang; Baik Lin Seong
Journal:  FASEB J       Date:  2018-03-23       Impact factor: 5.191

5.  Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: A systematic literature review.

Authors:  Saverio Caini; Madelon Kroneman; Therese Wiegers; Clotilde El Guerche-Séblain; John Paget
Journal:  Influenza Other Respir Viruses       Date:  2018-07-20       Impact factor: 4.380

6.  Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents.

Authors:  Masafumi Seki; Yuko Sakai-Tagawa; Atsuhiro Yasuhara; Yuji Watanabe
Journal:  IDCases       Date:  2019-10-01

7.  Characteristics of hospitalised patients with influenza in 2015-2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1.

Authors:  Tomer Kalish; Dan Miron; Maya Azrad; Hagai Rechnitzer; Hila Ben-Amram; Daniel Glikman; Avi Peretz
Journal:  Epidemiol Infect       Date:  2019-09-25       Impact factor: 2.451

Review 8.  Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC).

Authors:  Catherine Wei Min Ong; Giovanni Battista Migliori; Mario Raviglione; Gavin MacGregor-Skinner; Giovanni Sotgiu; Jan-Willem Alffenaar; Simon Tiberi; Cornelia Adlhoch; Tonino Alonzi; Sophia Archuleta; Sergio Brusin; Emmanuelle Cambau; Maria Rosaria Capobianchi; Concetta Castilletti; Rosella Centis; Daniela M Cirillo; Lia D'Ambrosio; Giovanni Delogu; Susanna M R Esposito; Jose Figueroa; Jon S Friedland; Benjamin Choon Heng Ho; Giuseppe Ippolito; Mateja Jankovic; Hannah Yejin Kim; Senia Rosales Klintz; Csaba Ködmön; Eleonora Lalle; Yee Sin Leo; Chi-Chiu Leung; Anne-Grete Märtson; Mario Giovanni Melazzini; Saeid Najafi Fard; Pasi Penttinen; Linda Petrone; Elisa Petruccioli; Emanuele Pontali; Laura Saderi; Miguel Santin; Antonio Spanevello; Reinout van Crevel; Marieke J van der Werf; Dina Visca; Miguel Viveiros; Jean-Pierre Zellweger; Alimuddin Zumla; Delia Goletti
Journal:  Eur Respir J       Date:  2020-10-01       Impact factor: 16.671

9.  Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period.

Authors:  Shu Qiao Yang; Jiu Xin Qu; Chen Wang; Xiao Min Yu; Ying Mei Liu; Bin Cao
Journal:  Clin Respir J       Date:  2013-11-26       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.